Clinical characteristics of patients from Quebec, Canada, with Morquio A syndrome: a longitudinal observational study.

In Quebec, Canada, Morquio A frequently manifests as a non-classical form of the syndrome due to a founder effect. Patients treated with elosulfase alfa generally show long-term improvement or stability in endurance and function, regardless of pathogenic variant.